Predictive value of daunorubicin accumulation and P-glycoprotein expression simultaneously determined using flow cytometry in adult acute myeloid leukemias;INTERET PREDICTIF DE L'ACCUMULATION INTRACELLULAIRE DE DAUNORUBICINE ET DE L'EXPRESSION DE LA GLYCOPROTEINE P DETERMINEES SIMULTANEMENT PAR CYTOMETRIE EN FLUX DANS LES LEUCEMIES AIGUES MYELOIDES DE L'ADULTE

Annales de Biologie Clinique

Volumn 54, Issue 1, 1996, Pages 17-19

  Guerci, A ^a   Merlin, J L ^b   Missoum, N ^a   Feldmann, L ^c   Marchal, S ^b   Guerci, O ^a  

^a CHU NANCY BRABOIS   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

^c Hopital Marin   (France)

Author keywords

Daunorubicin; Flow cytometry; Leukemia, myeloid, acute; Multidrug resistance; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN; GLYCOPROTEIN P; IDARUBICIN; MITOXANTRONE; MONOCLONAL ANTIBODY; QUININE; ZORUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; DRUG ACCUMULATION; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PREDICTION; PROTEIN EXPRESSION; RELAPSE; ACUTE DISEASE; ADULT; BLOOD; BONE MARROW; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; MYELOID LEUKEMIA; PROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; BONE MARROW; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID; MULTIVARIATE ANALYSIS; P-GLYCOPROTEIN; PHENOTYPE; PROSPECTIVE STUDIES;

EID: 0029716435     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Moscow JA, Cowan KH (1990) Multidrug resistance. Cancer Chemother Biol Resp Modif 11, 97-114
2. Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58, 137-171
3. Merlin JL, Missoum N, Marchal S, Guerci A, Tsuruo T, Guerci O (1993) Double labeling flow cytometry analysis of multidrug resistance in leukemias and Lymphomas. In: Drug resistance in leukemia lymphoma: the clinical value of laboratory studies (Kaspers GJL, Pieters R, Twentyman PR, Wiesenthal LM, Veerman AJP, eds). Harwood, Chur, 95-103
4. Merlin JL, Guerci A, Marchal S, Missoum N, Ramacci C, Humbert JC, Tsuruo T, Guerci O (1994) Comparative evaluation of S9788, verapamil and cyclosporin A in K562 human leukemia cell lines and in P-glycoprotein expressing samples from patients with hematological malignancies. Blood 84, 262-269
5. Verrelle P, Meissonnier F, Fonck Y, Feillel V, Dionet C, Kwiatowski F, Plagne R, Chassagne J (1991) Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast cancer. J Natl Cancer Inst 83, 111-116
6. Van Kalken CK, Van der Valk P, Hadisaputro MMN, Pieters R, Broxterman HJ, Kuiper CM, Scheffer GL, Veerman AJP, Meyer CJLM, Scheper RJ, Pinedo HM (1991) Differenciation dependent expression of P-glycoprotein in the normal and neoplastic kidney. Ann Oncol 2, 55-62
7. Axiotis CA, Monteagudo C, Merino MJ, LaPorte N, Neumann RD (1991) Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma. Am J Pathol 138, 799-805
8. Becker I, Becker KF, Meyermann R, Höllt V (1991) The multidrug-resistance gene mdr1 is expressed in human glial tumors. Acta Neuropathol 82, 516-519
9. Fuchs B, Ostmeier H, Suter L (1991) P-glycoprotein expression in malignant melanoma. J Cancer Res Clin Oncol 117, 168-171
10. Dalton WS, Grogan TM, Rybski JA, Scheper RJ, Richter L, Kailey J, Broxterman HJ, Pinedo HM, Salmon SE (1989) Immunohistochemical detection and quantification of P-glycoprotein in multiple drug-resistant human myeloma cells; association with level of drug resistance and drug accumulation. Blood 73, 747-752
11. Kuwazuru Y, Yoshimura A, Hanada S, Utsunomiya A, Makino T, Ishibashi K, Kodama M, Iwahashi M, Arima T, Akiyama SI (1990) Expression of the multidrug transporter P-glycoprotein in acute leukemia cells and correlation to clinical drug resistance. Cancer 66, 868-873
12. Larsson R, Kristensen J, Sandberg C, Nygren P (1992) Laboratory determination of chemoterapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA). Int J Cancer 50, 177-185
13. Marie JP, Zittoun R, Sikic B (1991) Multidrug resistance gene (mdr1) expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 78, 586-591
14. Nooter K, Sonneveld P, Oostrum R, Herweijer H, Hagenbeek T, Valerio D (1990) Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin A Int J Cancer 45, 263-268
15. Ubezio P, Limonta M, D'Incalci M, Damia G, Masera G, Giudici G, Wolverto JS, Beck WT (1989) Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukemia. Eur J Cancer Clin Oncol 25, 1895-1899
16. Cros S, Guilbaud N, Berhon M, Dunn T, Regnier G, Dhainaut A, Atassi G, Bizzari JP (1992) In vivo evidence of complete reversion of vincristine resistance by a new triazinopoperidine derivative S9788 in P388/VCR leukemia model. Cancer Chemother Pharmacol 30, 491-494
17. Kato S, Ideguchi H, Muta K, Nishimura J, Nawata H (1991) Absence of correlation between cytotoxicity and drug transport by P-glycoprotein in clinical leukemic cells. Eur J Haematol 47, 146-151
18. Merlin JL, Marchai S, Ramacci C, Dieterlen A, Schultz G, Lucas C, Poullain MG, Berlion M (1996) Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells. Cytometry (à paraître)
19. Merlin JL, Morjani H, Manfait M, Marchai S, Ramacci C, Poullain MG, Paraire M, Lucas C (1995) Evaluation of combinations of S9788 with verapamil, cyclosporine A or SDZ-PSC833 in multidrug resistant cells. Proc Am Assoc Cancer Res 36, 343